OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang is reportedly leaving to launch an AI drug discovery startup, with other OpenAI researchers expected to join. The company is in talks to raise $200 million at a $2 billion valuation, potentially led by Lightspeed. Wang's startup may focus on finding new uses for existing or failed drugs. This follows significant investor interest in AI for life sciences, as seen with recent large funding rounds for similar companies like Chai Discovery and Isomorphic Labs.